Carboranylanilinoquinazoline EGFR-inhibitors: toward 'lead-to-candidate' stage in the drug-development pipeline.
Future Med Chem
; 11(17): 2273-2285, 2019 09.
Article
in En
| MEDLINE
| ID: mdl-31581913
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quinazolines
/
Brain Neoplasms
/
Protein Kinase Inhibitors
/
ErbB Receptors
/
Glioma
/
Aniline Compounds
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Future Med Chem
Year:
2019
Document type:
Article
Affiliation country: